These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neurological glycogen storage diseases and emerging therapeutics. Colpaert M; Singh PK; Donohue KJ; Pires NT; Fuller DD; Corti M; Byrne BJ; Sun RC; Vander Kooi CW; Gentry MS Neurotherapeutics; 2024 Sep; 21(5):e00446. PubMed ID: 39277505 [TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease. Yi H; Sun T; Armstrong D; Borneman S; Yang C; Austin S; Kishnani PS; Sun B J Mol Med (Berl); 2017 May; 95(5):513-521. PubMed ID: 28154884 [TBL] [Abstract][Full Text] [Related]
4. Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion. Brewer MK; Uittenbogaard A; Austin GL; Segvich DM; DePaoli-Roach A; Roach PJ; McCarthy JJ; Simmons ZR; Brandon JA; Zhou Z; Zeller J; Young LEA; Sun RC; Pauly JR; Aziz NM; Hodges BL; McKnight TR; Armstrong DD; Gentry MS Cell Metab; 2019 Oct; 30(4):689-705.e6. PubMed ID: 31353261 [TBL] [Abstract][Full Text] [Related]
6. Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments. Müller D BioDrugs; 2014 Apr; 28(2):123-31. PubMed ID: 24018469 [TBL] [Abstract][Full Text] [Related]
7. Novel method for detection of glycogen in cells. Skurat AV; Segvich DM; DePaoli-Roach AA; Roach PJ Glycobiology; 2017 May; 27(5):416-424. PubMed ID: 28077463 [TBL] [Abstract][Full Text] [Related]
14. The Dawn of a New Era: Targeting the "Undruggables" with Antibody-Based Therapeutics. Qian L; Lin X; Gao X; Khan RU; Liao JY; Du S; Ge J; Zeng S; Yao SQ Chem Rev; 2023 Jun; 123(12):7782-7853. PubMed ID: 37186942 [TBL] [Abstract][Full Text] [Related]
16. Co-administered antibody improves penetration of antibody-dye conjugate into human cancers with implications for antibody-drug conjugates. Lu G; Nishio N; van den Berg NS; Martin BA; Fakurnejad S; van Keulen S; Colevas AD; Thurber GM; Rosenthal EL Nat Commun; 2020 Nov; 11(1):5667. PubMed ID: 33168818 [TBL] [Abstract][Full Text] [Related]
17. Coming-of-Age of Antibodies in Cancer Therapeutics. Ayyar BV; Arora S; O'Kennedy R Trends Pharmacol Sci; 2016 Dec; 37(12):1009-1028. PubMed ID: 27745709 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Kishnani PS; Goldstein J; Austin SL; Arn P; Bachrach B; Bali DS; Chung WK; El-Gharbawy A; Brown LM; Kahler S; Pendyal S; Ross KM; Tsilianidis L; Weinstein DA; Watson MS; Genet Med; 2019 Apr; 21(4):772-789. PubMed ID: 30659246 [TBL] [Abstract][Full Text] [Related]
19. Antibodies and associates: Partners in targeted drug delivery. Kennedy PJ; Oliveira C; Granja PL; Sarmento B Pharmacol Ther; 2017 Sep; 177():129-145. PubMed ID: 28315359 [TBL] [Abstract][Full Text] [Related]
20. Enzyme therapy for hypertrophic cardiomyopathy in non-classical Pompe disease: Effectiveness of treatment. Kim J; Kim H; Eun LY Pediatr Int; 2017 Jan; 59(1):107-108. PubMed ID: 28102630 [No Abstract] [Full Text] [Related] [Next] [New Search]